Trials / Unknown
UnknownNCT06324825
Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
Fuzhegn Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- Sponsor
- Peking University First Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Fuzheng Nizeng Formula (FZNZ) is derived from the classic formula Liujunzi Decoction. Former pilot study found that FZNZ promoted the recovery of gastric atrophy and relieve the relative symptoms. This study is to evaluate its efficacy for chronic atrophic gastritis with low-grade intraepithelial neoplasia, compared with positive control Molduodan granule.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fuzhegn Nizeng Decoction | Subjects taking prepared Fuzhegn Nizeng granules twice daily for 6 month. |
| DRUG | Moluodan granules | Subjects taking prepared Moluodan granules 9g twice daily for 6 month. |
Timeline
- Start date
- 2022-10-24
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-03-22
- Last updated
- 2024-03-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06324825. Inclusion in this directory is not an endorsement.